News and Opinions

by Jacob Bell - BioPharmaDive - The agency has now cleared Shanghai-based Unixell to begin human studies in the U.S. for an allogeneic, stem cell-derived therapy targeting focal epilepsy. For the first time, the Food and Drug Administration is allowing a certain kind...

By PNAS.org - In December 2025, the US Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Review (CBER) approved a gene-based stem cell therapy for Wiskott–Aldrich syndrome, a rare and life-threatening genetic disease. This decision was...

By Steve Lundeberg - Oregon State University - by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells. Findings of the study spearheaded by Oregon State University College of Pharmacy graduate student Antony...

By Kyoto University - Nanogel integrated spheroids increase cell retention and repair injured swallowing muscles Kyoto, Japan -- Swallowing is a fundamental human function that supports nutrition and communication. Damage to swallowing muscles can reduce quality of...

By Stanford Medicine News - Stanford Medicine scientists are launching a clinical trial of prenatal transplants, using stem cells from the mother, to treat a rare genetic disease called Fanconi anemia before a baby is born. Stanford Medicine pediatric hematologist...

By Darren Orf - Popular Mechanics - Scientists trained a brain organoid to solve a well-known engineering task, and its success demonstrates the increasing complexity of lab-grown brains. While creating organs sounds like sci-fi fodder, scientists have actually...

by James Felton - IFLScience - Swiss pharmaceutical company Novartis has settled a lawsuit by the estate of Henrietta Lacks, which alleged that the company unfairly profited from her "immortal" cell line, taken without her knowledge or consent in 1951 and still widely...

By Elizabeth Dougherty - Dana-Farber Cancer Institute - In the early 1970s, the field of genetics was confined to the study of bacteria and viruses. Conventional wisdom at the time was that the tools of molecular biology couldn't be used to study human diseases. Human...

By Erin Baily - UC Davis Health - For Hai Trinh, his disease started gradually. Fatigue. Bruising easily. He thought little of it. As a mechanic, husband and father of two girls, he just kept pushing forward, attributing the persistent health challenges to his long...

By Jamie Bartosch - UChicago Medicine - “I was so sick and tired; I knew I couldn’t keep doing chemo,” said Cordle, 51, who lives in Mapleton, Illinois, just outside Peoria. The next step would be stem cell transplantation, also known as bone marrow transplantation....

By Melissa Rohman - NorthWwestern Medicine - CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone lymphoma, according to a recent clinical trial published in The Lancet. Marginal zone lymphoma...

By Oregon State University - Science Daily - Scientists at Oregon State University have engineered a powerful new nanomaterial that zeroes in on cancer cells and destroys them from the inside out. Designed to exploit cancer’s unique chemistry—its acidity and high...

By Columbia University Irving Medical Center - CAR-T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers. Columbia researchers have now found that a new type...

By Elise Takahama - Seattle Times - A King County jury has awarded $24 million to the family of a man who died a day after treatment at a Seattle stem cell center. Mike Trujillo was 62, a longtime electrician who ran an electrical company in Colorado. After being...

By Will Maddox - Fierce Biotech - After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate. The agreement, announced in Beam’s end-of-year...

by Lynda Charters - Opthamology - A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO), according to a press release...

By Neuroscience News.com - Spinal cord injuries have long been considered permanent because neurons in the central nervous system lack the natural ability to regrow. However, researchershave developed a novel, 3D-printed implant that could change that. The study...

By Karen Guzman - Yale News - Yale scientists have engineered natural killer cells that eliminate solid tumors in mouse models. The study may lead to a simpler, “off the shelf” immunotherapy for hard-to-treat cancers. Since scientists first discovered that human...

By Edward Chen - Nature - Elderly people with frailty, which affects up to one-quarter of over-50s, increased their endurance after a single dose of stem cells. A single dose of stem cells can help older people with frailty to build up their endurance, a study finds1....

By Keck Medicine of US - SciTechDaily - A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease. In Parkinson’s disease, the problem starts deep in the brain, where a small group of...